We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ELTX market cap is 52.66M. The company's latest EPS is USD -3.2614 and P/E is -1.44.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.98M | -10.56M | -9.39M | -10.24M | -10.92M |
| Net Income | -11.05M | -10.66M | -8.95M | -11.83M | -7.23M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.49M | 2.88M | 28.31M | 2.3M | 0 |
| Operating Income | -38.59M | -55.34M | -39.31M | -39.62M | -35.75M |
| Net Income | -40.66M | -80.11M | -54.57M | -38.81M | -35.2M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.62M | 30.99M | 27.15M | 24.48M | 15.75M |
| Total Liabilities | 14.06M | 17.7M | 15.77M | 19.61M | 17.4M |
| Total Equity | 23.56M | 13.29M | 11.37M | 4.87M | -1.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.89M | 47.35M | 96.51M | 52.79M | 27.15M |
| Total Liabilities | 30.47M | 137.8M | 15.01M | 9.02M | 15.77M |
| Total Equity | -18.59M | -90.45M | 81.51M | 43.77M | 11.37M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.61M | -22.8M | -32.69M | -12.12M | -21.05M |
| Investing | 13k | -32k | -32k | 3k | -39k |
| Financing | 31.55M | 31.61M | 38.61M | 11.02M | 11.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.59M | -22.89M | -52.64M | -38.39M | -32.69M |
| Investing | -242k | -41k | -382k | N/A | -32k |
| Financing | 4.89M | 52.41M | 107.17M | -60k | 38.61M |
| Market Cap | 52.66M |
| Price to Earnings Ratio | -1.44 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.93 |
| Price to Book Ratio | 4.46 |
| Dividend Yield | - |
| Shares Outstanding | 10.79M |
| Average Volume (1 week) | 25.09k |
| Average Volume (1 Month) | 26.27k |
| 52 Week Change | -19.47% |
| 52 Week High | 11.45 |
| 52 Week Low | 2.96 |
| Spread (Intraday) | 3.79 (54.14%) |
| Company Name | Elicio Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.elicio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
